ANTISENSE MOLECULES AND THEIR USES FOR THE TREATMENT OF CORONAVIRUS INFECTION, IN PARTICULAR THE TREATMENT OF COVID-19 RELATED TO SARS-COV-2 INFECTION

• Main Authors: DA COSTA, Bruno, LE PODER, Sophie, ÉLÉOUËT, Jean François, DELMAS, Bernard, MEUNIER, Nicolas, POLLET, Sophie, BARREY, Eric, FITZPATRICK MARIN, Christopher Shawn, BURZIO MENENDEZ, Verónica Andrea
• Format: Patent
• Language: English; French
• Published: 25.07.2024
• Subjects: BEER; BIOCHEMISTRY; CHEMISTRY; COMPOSITIONS THEREOF; CULTURE MEDIA; ENZYMOLOGY; HUMAN NECESSITIES; HYGIENE; MEDICAL OR VETERINARY SCIENCE; METALLURGY; MICROBIOLOGY; MICROORGANISMS OR ENZYMES; MUTATION OR GENETIC ENGINEERING; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS; SPIRITS; VINEGAR; WINE

The present invention relates to a new antisense oligonucleotide, a pharmaceutical composition comprising it and their use for preventing or treating infection by coronavirus, especially by SARS-CoV-2 virus which causes the infection disease COVID-19. La présente invention concerne un nouvel oligonucléotide antisens, une composition pharmaceutique le comprenant et leur utilisation pour prévenir ou traiter une infection par coronavirus, en particulier par le virus du SARS-CoV-2 qui provoque la maladie infectieuse COVID-19.